OPC 15161

Drug Profile

OPC 15161

Alternative Names: NF 1616904; NP 161904

Latest Information Update: 05 Mar 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Osaka University; Otsuka Pharmaceutical
  • Class Anti-inflammatories; Anti-ischaemics; Pyrazines; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Glomerulonephritis

Most Recent Events

  • 05 Mar 2001 Discontinued-II for Glomerulonephritis in Japan (Unknown route)
  • 01 Jul 1998 Suspended-II for Glomerulonephritis in Japan (Unknown route)
  • 25 Jul 1995 Phase-II clinical trials for Glomerulonephritis in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top